Patents by Inventor Richard Todd Darrington

Richard Todd Darrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azithromycin combination for emesis control in mammals
    Publication number: 20040063649
    Abstract: The invention is directed to a method of treating cancer or a bacterial or protozoal infection in a mammalian subject in need of such treatment. The method comprises the adjunctive administration of pharmaceutically effective amounts of a macrolide antibiotic and a Substance P antagonist. The invention also encompasses a method of preventing or treating emesis associated with macrolide antibiotic administration. The invention further encompasses novel compositions comprising a macrolide antibiotic and a Substance P antagonist.
    Type: Application
    Filed: September 18, 2003
    Publication date: April 1, 2004
    Applicant: Pfizer Inc
    Inventors: Dennis M. Godek, Richard Todd Darrington, Elizabeth Fraering Illyes
  • Azithromycin combination for emesis control in mammals
    Publication number: 20030018049
    Abstract: The invention is directed to a method of treating cancer or a bacterial or protozoal infection in a mammalian subject in need of such treatment. The method comprises the adjunctive administration of pharmaceutically effective amounts of a macrolide antibiotic and a Substance P antagonist. The invention also encompasses a method of preventing or treating emesis associated with macrolide antibiotic administration. The invention further encompasses novel compositions comprising a macrolide antibiotic and a Substance P antagonist.
    Type: Application
    Filed: August 22, 2002
    Publication date: January 23, 2003
    Inventors: Dennis M. Godek, Richard Todd Darrington, Elizabeth Fraering Illyes
  • Azithromycin combination for emesis control in mammals
    Publication number: 20020016301
    Abstract: The invention is directed to a method of treating cancer or a bacterial or protozoal infection in a mammalian subject in need of such treatment. The method comprises the adjunctive administration of pharmaceutically effective amounts of a macrolide antibiotic and a Substance P antagonist. The invention also encompasses a method of preventing or treating emesis associated with macrolide antibiotic administration. The invention further encompasses novel compositions comprising a macrolide antibiotic and a Substance P antagonist.
    Type: Application
    Filed: August 15, 2001
    Publication date: February 7, 2002
    Inventors: Dennis M. Godek, Richard Todd Darrington, Elizabeth Fraering Illyes